Annual SGA
$157.56 M
-$14.95 M-8.66%
December 1, 2024
Summary
- As of February 20, 2025, ADPT annual SGA is $157.56 million, with the most recent change of -$14.95 million (-8.66%) on December 1, 2024.
- During the last 3 years, ADPT annual SGA has fallen by -$12.40 million (-7.30%).
- ADPT annual SGA is now -14.43% below its all-time high of $184.13 million, reached on December 31, 2022.
Performance
ADPT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$39.63 M
+$1.82 M+4.82%
December 1, 2024
Summary
- As of February 20, 2025, ADPT quarterly SGA is $39.63 million, with the most recent change of +$1.82 million (+4.82%) on December 1, 2024.
- Over the past year, ADPT quarterly SGA has increased by +$1.82 million (+4.82%).
- ADPT quarterly SGA is now -21.11% below its all-time high of $50.24 million, reached on March 31, 2022.
Performance
ADPT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$5.00 B
-$159.49 M-3.29%
December 1, 2024
Summary
- As of February 20, 2025, ADPT TTM SGA is -$5.00 billion, with the most recent change of -$159.49 million (-3.29%) on December 1, 2024.
- Over the past year, ADPT TTM SGA has dropped by -$5.16 billion (-3216.39%).
- ADPT TTM SGA is now -1591.02% below its all-time high of -$295.91 million.
Performance
ADPT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ADPT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.7% | +4.8% | -3216.4% |
| 3 y3 years | -7.3% | -12.9% | -2721.7% |
| 5 y5 years | +129.1% | -12.9% | -2721.7% |
ADPT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.4% | at low | -21.1% | +4.8% | -97.8% | at low |
| 5 y | 5-year | -14.4% | +129.1% | -21.1% | +90.3% | -269.1% | at low |
| alltime | all time | -14.4% | +381.6% | -21.1% | +313.3% | -1591.0% | at low |
Adaptive Biotechnologies Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $157.56 M(-8.7%) | $39.63 M(+4.8%) | $157.56 M(-1.9%) |
| Sep 2024 | - | $37.81 M(-1.0%) | $160.57 M(-1.7%) |
| Jun 2024 | - | $38.21 M(-8.8%) | $163.32 M(-4.7%) |
| Mar 2024 | - | $41.92 M(-1.7%) | $171.29 M(-0.7%) |
| Dec 2023 | $172.51 M(-6.3%) | $42.63 M(+5.1%) | $172.51 M(-2.0%) |
| Sep 2023 | - | $40.57 M(-12.1%) | $176.03 M(-1.0%) |
| Jun 2023 | - | $46.17 M(+7.0%) | $177.72 M(+0.4%) |
| Mar 2023 | - | $43.14 M(-6.5%) | $177.03 M(-3.9%) |
| Dec 2022 | $184.13 M(+8.3%) | $46.14 M(+9.2%) | $184.13 M(-2.1%) |
| Sep 2022 | - | $42.27 M(-7.1%) | $188.03 M(-1.5%) |
| Jun 2022 | - | $45.48 M(-9.5%) | $190.86 M(+3.4%) |
| Mar 2022 | - | $50.24 M(+0.4%) | $184.66 M(+8.6%) |
| Dec 2021 | $169.97 M | $50.04 M(+11.0%) | $169.97 M(+11.9%) |
| Sep 2021 | - | $45.10 M(+14.8%) | $151.87 M(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $39.28 M(+10.5%) | $133.32 M(+10.5%) |
| Mar 2021 | - | $35.54 M(+11.3%) | $120.61 M(+8.8%) |
| Dec 2020 | $110.89 M(+61.2%) | $31.94 M(+20.3%) | $110.89 M(+11.1%) |
| Sep 2020 | - | $26.55 M(-0.1%) | $99.78 M(+9.9%) |
| Jun 2020 | - | $26.57 M(+2.9%) | $90.80 M(+13.8%) |
| Mar 2020 | - | $25.83 M(+24.0%) | $79.79 M(+16.0%) |
| Dec 2019 | $68.78 M(+53.2%) | $20.83 M(+18.5%) | $68.78 M(+10.0%) |
| Sep 2019 | - | $17.58 M(+13.0%) | $62.52 M(+12.2%) |
| Jun 2019 | - | $15.56 M(+5.0%) | $55.72 M(+11.2%) |
| Mar 2019 | - | $14.82 M(+1.8%) | $50.13 M(+11.7%) |
| Dec 2018 | $44.90 M(+37.2%) | $14.57 M(+35.1%) | $44.90 M(+48.0%) |
| Sep 2018 | - | $10.78 M(+8.2%) | $30.33 M(+55.1%) |
| Jun 2018 | - | $9.96 M(+3.9%) | $19.55 M(+103.9%) |
| Mar 2018 | - | $9.59 M | $9.59 M |
| Dec 2017 | $32.71 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual SGA?
- What is the all time high annual SGA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual SGA year-on-year change?
- What is Adaptive Biotechnologies quarterly SGA?
- What is the all time high quarterly SGA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly SGA year-on-year change?
- What is Adaptive Biotechnologies TTM SGA?
- What is the all time high TTM SGA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM SGA year-on-year change?
What is Adaptive Biotechnologies annual SGA?
The current annual SGA of ADPT is $157.56 M
What is the all time high annual SGA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual SGA is $184.13 M
What is Adaptive Biotechnologies annual SGA year-on-year change?
Over the past year, ADPT annual SGA has changed by -$14.95 M (-8.66%)
What is Adaptive Biotechnologies quarterly SGA?
The current quarterly SGA of ADPT is $39.63 M
What is the all time high quarterly SGA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly SGA is $50.24 M
What is Adaptive Biotechnologies quarterly SGA year-on-year change?
Over the past year, ADPT quarterly SGA has changed by +$1.82 M (+4.82%)
What is Adaptive Biotechnologies TTM SGA?
The current TTM SGA of ADPT is -$5.00 B
What is the all time high TTM SGA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM SGA is -$295.91 M
What is Adaptive Biotechnologies TTM SGA year-on-year change?
Over the past year, ADPT TTM SGA has changed by -$5.16 B (-3216.39%)